Trial site
Belo Horizonte
- 12running trials
- 6closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)5 trials
- Coronary artery disease3 trials
- Familial hypercholesterolaemia3 trials
- IgA nephropathy3 trials
- Stroke3 trials
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Gastric and oesophageal cancer1 trial
- Heart failure1 trial
- Lung cancer1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 313 trials
- Phase 23 trials
- Phase 42 trials
- Status
- Active, not recruiting10 trials
- Completed5 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals18 trials
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Familial hypercholesterolaemia1 recruiting
- Lupus (SLE)1 recruiting
Closed trials
Terminated
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026